UK markets close in 7 hours 59 minutes

Molecular Partners AG (MOLN)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
3.8900+0.2800 (+7.76%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 115.00M
Enterprise value -85.35M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)16.47
Price/book (mrq)0.66
Enterprise value/revenue -12.13
Enterprise value/EBITDA 1.43

Trading information

Stock price history

Beta (5Y monthly) 0.78
52-week change 3-41.12%
S&P500 52-week change 321.08%
52-week high 37.3200
52-week low 33.3200
50-day moving average 34.0861
200-day moving average 34.6691

Share statistics

Avg vol (3-month) 33.02k
Avg vol (10-day) 33.62k
Shares outstanding 532.87M
Implied shares outstanding 636.56M
Float 816.99M
% held by insiders 10.00%
% held by institutions 12.63%
Shares short (15 Apr 2024) 456.35k
Short ratio (15 Apr 2024) 412.93
Short % of float (15 Apr 2024) 4N/A
Short % of shares outstanding (15 Apr 2024) 40.17%
Shares short (prior month 15 Mar 2024) 449.02k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CHF.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,613.18%

Management effectiveness

Return on assets (ttm)-16.58%
Return on equity (ttm)-30.12%

Income statement

Revenue (ttm)7.04M
Revenue per share (ttm)0.22
Quarterly revenue growth (yoy)-61.70%
Gross profit (ttm)N/A
EBITDA -60.18M
Net income avi to common (ttm)-61.98M
Diluted EPS (ttm)-2.0700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)186.89M
Total cash per share (mrq)5.69
Total debt (mrq)3.65M
Total debt/equity (mrq)2.07%
Current ratio (mrq)13.35
Book value per share (mrq)5.37

Cash flow statement

Operating cash flow (ttm)-59.01M
Levered free cash flow (ttm)-34.2M